EP1567158A4
Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 6 November 2023, 2.9 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
28 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22 Sheet 23 Sheet 24 Sheet 25 Sheet 26 Sheet 27 Sheet 28
Every citation, both waysCites: the store holds 6 of 7
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO02059106A1 | Cites | World Intellectual Property Organization (WIPO) | DX | Search report | 1-26 |
| WO02064083A2 | Cites | World Intellectual Property Organization (WIPO) | X | Search report | 1-26 |
| US2002049231A1 | Cites | United States of America | X | Search report | 1-26 |
| US6316471B1 | Cites | United States of America | DX | Search report | 1-26 |
| WO02059106A | Cites | World Intellectual Property Organization (WIPO) | – | – | – |
| WO02064083A | Cites | World Intellectual Property Organization (WIPO) | – | – | – |
| DATABASE PHARMAML [online] "Celgene's Revimid an orphan drug, says FDA", XP002369094, retrieved from STN Database accession no. 1659300 | Non-patent | – | – | Search report | – |
| DATABASE NLDB [online] "Celgene drug promises activity in solid tumors", XP002369095, retrieved from STN Database accession no. 2002:35280 | Non-patent | – | – | Search report | – |
| FIGG WILLIAM D ET AL: "Inhibition of angiogenesis: Treatment options for patients with metastatic prostate cancer", INVESTIGATIONAL NEW DRUGS, vol. 20, no. 2, May 2002 (2002-05-01), pages 183 - 194, XP002369096, ISSN: 0167-6997 | Non-patent | – | – | Search report | – |
| RICHARDSON P G ET AL: "A phase 1 study of oral CC5013, an immunomodulatory thalidomide (thal) derivative, in patients with relapsed and refractory multiple myeloma (MM)", BLOOD, vol. 98, no. 11 Part 1, 16 November 2001 (2001-11-16), & 43RD ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY, PART 1; ORLANDO, FLORIDA, USA; DECEMBER 07-11, 2001, pages 775a, XP009062262, ISSN: 0006-4971 | Non-patent | – | – | Search report | – |
| D'AMATO R J ET AL: "MECHANISM OF ACTION OF THALIDOMIDE AND 3-AMINOTHALIDOMIDE IN MULTIPLE MYELOMA", SEMINARS IN ONCOLOGY, W.B. SAUNDERS,, US, vol. 28, no. 6, December 2001 (2001-12-01), pages 597 - 601, XP008028089, ISSN: 0093-7754 | Non-patent | – | – | Search report | – |
| LENTZSCH S ET AL: "S-3-amino-phthalimido-glutarimide inhibits angiogenesis and growth of B-cell neoplasias in mice", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 62, 15 April 2002 (2002-04-15), pages 2300 - 2305, XP002959459, ISSN: 0008-5472 | Non-patent | – | – | Search report | – |
525 members in 41 offices
Priority claims14
| Document | Office | Kind | Date |
|---|---|---|---|
| 424600P | United States of America | – | |
| 42460002 | United States of America | P | |
| 42460002 | United States of America | P | |
| 438213 | United States of America | – | |
| 43821303 | United States of America | A | |
| 43821303 | United States of America | A | |
| 0335544 | United States of America | W | |
| 0335544 | United States of America | W | |
| 424600P | – | – | – |
| 438213 | – | – | – |
| US20020424600P | – | – | – |
| US2003035544 | – | – | – |
| US20030438213 | – | – | – |
| WO2003US35544 | – | – | – |
Members525
| Document | Office | Kind | |
|---|---|---|---|
| CA2476983A1 | Canada | A1 | |
| CA2486141A1 | Canada | A1 | |
| CA2672000A1 | Canada | A1 | |
| CA2727824A1 | Canada | A1 | |
| CA2727830A1 | Canada | A1 | |
| CA2752122A1 | Canada | A1 | |
| CA2752124A1 | Canada | A1 | |
| CA2752127A1 | Canada | A1 | |
| CA2752140A1 | Canada | A1 | |
| CA2794060A1 | Canada | A1 | |
| CA2794297A1 | Canada | A1 | |
| CA2855306A1 | Canada | A1 | |
| CA2855359A1 | Canada | A1 | |
| WO03097040A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO03097052A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003234624A1 | Australia | A1 | |
| AU2003234626A1 | Australia | A1 | |
| AU2003234626C1 | Australia | C1 | |
| WO03097052A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2004029832A1 | United States of America | A1 | |
| CA2505128A1 | Canada | A1 | |
| CA2505131A1 | Canada | A1 | |
| WO2004043377A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2004043378A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003290651A1 | Australia | A1 | |
| AU2003290652A1 | Australia | A1 | |
| WO2004043377A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2004043378A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AU2004240548A1 | Australia | A1 | |
| CA2525557A1 | Canada | A1 | |
| WO2004103274A2 | World Intellectual Property Organization (WIPO) | A2 | |
| TW200500355A | Taiwan Province of China | A | |
| TW200501945A | Taiwan Province of China | A | |
| KR20050010812A | Republic of Korea | A | |
| KR20050010815A | Republic of Korea | A | |
| NO20055976L | Norway | L | |
| MXPA04011310A | Mexico | A | |
| MXPA04011311A | Mexico | A | |
| EP1505973A2 | European Patent Office (EPO) | A2 | |
| WO2004103274A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AU2004270211A1 | Australia | A1 | |
| CA2537092A1 | Canada | A1 | |
| CA2687924A1 | Canada | A1 | |
| CA2687927A1 | Canada | A1 | |
| CA2688694A1 | Canada | A1 | |
| CA2688695A1 | Canada | A1 | |
| CA2688708A1 | Canada | A1 | |
| CA2688709A1 | Canada | A1 | |
| CA2741412A1 | Canada | A1 | |
| CA2741575A1 | Canada | A1 | |
| WO2005023192A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2005096351A1 | United States of America | A1 | |
| KR20050072801A | Republic of Korea | A | |
| KR20050072802A | Republic of Korea | A | |
| EP1556033A1 | European Patent Office (EPO) | A1 | |
| MXPA05004734A | Mexico | A | |
| US2005176681A1 | United States of America | A1 | |
| HK1072180A1 | Hong Kong, China | A1 | |
| EP1567154A2 | European Patent Office (EPO) | A2 | |
| EP1567158A2 | European Patent Office (EPO) | A2 | |
| BR0316050A | Brazil | A | |
| CN1668296A | China | A | |
| BR0316057A | Brazil | A | |
| WO2005023192A3 | World Intellectual Property Organization (WIPO) | A3 | |
| MXPA05004780A | Mexico | A | |
| JP2005530780A | Japan | A | |
| JP2005530784A | Japan | A | |
| US2005234017A1 | United States of America | A1 | |
| IS8127A | Iceland | A | |
| CN1697655A | China | A | |
| IL165254D0 | Israel | D0 | |
| IL165258D0 | Israel | D0 | |
| KR20060012618A | Republic of Korea | A | |
| US2006030594A1 | United States of America | A1 | |
| CN1735412A | China | A | |
| CN1735415A | China | A | |
| US2006035955A1 | United States of America | A1 | |
| MXPA05012155A | Mexico | A | |
| IS8340A | Iceland | A | |
| AU2003234626B2 | Australia | B2 | |
| JP2006508131A | Japan | A | |
| AR047994A1 | Argentina | A1 | |
| EP1635826A2 | European Patent Office (EPO) | A2 | |
| CR8146A | Costa Rica | A | |
| US2006069065A1 | United States of America | A1 | |
| IL171960D0 | Israel | D0 | |
| PE20060284A1 | Peru | A1 | |
| JP2006514689A | Japan | A | |
| EP1505973A4 | European Patent Office (EPO) | A4 | |
| EP1567158A4This record | European Patent Office (EPO) | A4 | |
| US2006105993A1 | United States of America | A1 | |
| BRPI0410306A | Brazil | A | |
| EP1556033A4 | European Patent Office (EPO) | A4 | |
| EP1567154A4 | European Patent Office (EPO) | A4 | |
| MXPA06001994A | Mexico | A | |
| ZA200409388B | South Africa | B | |
| NO20061528L | Norway | L | |
| NO20150253L | Norway | L | |
| RU2005139133A | Russian Federation | A | |
| EP1667682A2 | European Patent Office (EPO) | A2 |
Showing 100 of 525
19 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Application withdrawnWithdrawn18W | 18W | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION HAS BEEN WITHDRAWNSTAA | STAA | |
| First examination report despatched17Q | 17Q | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | |
| Supplementary search report drawn up and despatchedA4 | A4 | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | |
| Requested extension states of the european patent have changedRAX | RAX | |
| Requested extension states of the european patent have changedRAX | RAX | |
| Requested extension states of the european patent have changedRAX | RAX | |
| Requested extension states of the european patent have changedRAX | RAX | |
| Request for examination filed17P | 17P | |
| Designated contracting statesAK | AK | |
| Request for extension of the european patentAX | AX | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI |
Numbers
- Publication
- 1567158
- Publication, DOCDB
- 1567158
- Publication, EPODOC
- EP1567158
- Application
- 3783233
- Application, DOCDB
- 03783233
- Application, EPODOC
- EP20030783233
Titles3
- German
- VERFAHREN UNDZUSAMMENSETZUNGEN MIT IMMUNOMODULATORISCHEN VERBINDUNGEN ZUR BEHANDLUNG VON BZW.BETREUUNG BEI KREBS UND ANDEREN KRANKHEITEN
- English
- METHODS AND COMPOSITIONS USING IMMUNOMODULATORY COMPOUNDS FOR TREATMENT AND MANAGEMENT OF CANCERS AND OTHER DISEASES
- French
- PROCEDES ET COMPOSITIONS UTILISANT DES COMPOSES IMMUNOMODULATEURS POUR TRAITER ET MAITRISER DES CANCERS ET D'AUTRES MALADIES
Classification
- CPC, 45
- A61K31/445
- A61K31/454
- A61K31/00
- A61K31/40
- A61K31/425
- A61K31/515
- A61K45/06
- A61K31/4035
- A61K31/4439
- A61K31/573
- A61K31/198
- A61K31/475
- A61K31/675
- A61K31/704
- A61K31/7048
- A61P1/02
- A61P17/00
- A61P17/02
- A61P19/02
- A61P19/08
- A61P27/02
- A61P27/06
- A61P27/14
- A61P29/00
- A61P31/00
- A61P31/04
- A61P31/10
- A61P31/12
- A61P33/02
- A61P35/00
- A61P35/04
- A61P37/02
- A61P37/06
- A61P43/00
- A61P7/06
- A61P9/00
- A61P9/10
- Y02A50/30
- C07D401/00
- A61K35/12
- A61K39/3955
- A61K2300/00
- A61K9/0053
- A61K9/4858
- A61K9/4866
- IPC, 9
- A61K31 00
- A61K31 40
- A61K31 425
- A61K31 445
- A61K31 454
- A61K31 515
- A61K45 06
- A61P35 00
- A61P35 04
Designated states2
- Contracting states, 1
- Türkiye
- Extension states, 1
- North Macedonia